Icon (ICLR) Set to Announce Quarterly Earnings on Thursday

Icon (NASDAQ:ICLR) is scheduled to be announcing its earnings results before the market opens on Thursday, February 15th. Analysts expect the company to announce earnings of $1.41 per share for the quarter.

Shares of Icon (NASDAQ:ICLR) opened at $107.01 on Thursday. The firm has a market capitalization of $5,770.00, a P/E ratio of 20.78, a P/E/G ratio of 1.46 and a beta of 0.48. Icon has a 52 week low of $76.46 and a 52 week high of $124.48. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.90 and a current ratio of 1.90.

A hedge fund recently raised its stake in Icon stock. Vanguard Group Inc. raised its position in Icon Plc (NASDAQ:ICLR) by 19.8% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 14,545 shares of the medical research company’s stock after buying an additional 2,400 shares during the quarter. Vanguard Group Inc.’s holdings in Icon were worth $1,422,000 as of its most recent filing with the Securities and Exchange Commission. 89.43% of the stock is currently owned by institutional investors and hedge funds.

Several equities research analysts recently weighed in on ICLR shares. Zacks Investment Research cut Icon from a “buy” rating to a “hold” rating in a research note on Wednesday, November 1st. Barclays boosted their target price on Icon from $108.00 to $120.00 and gave the stock an “equal weight” rating in a research note on Friday, October 27th. Credit Suisse Group restated an “outperform” rating and set a $120.00 target price (up previously from $105.00) on shares of Icon in a research note on Monday, October 16th. ValuEngine upgraded Icon from a “hold” rating to a “buy” rating in a research note on Sunday, December 31st. Finally, KeyCorp restated an “overweight” rating and set a $125.00 target price (up previously from $115.00) on shares of Icon in a research note on Monday, November 13th. They noted that the move was a valuation call. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the stock. The company has a consensus rating of “Buy” and an average target price of $124.55.

COPYRIGHT VIOLATION NOTICE: This piece of content was posted by American Banking News and is the sole property of of American Banking News. If you are viewing this piece of content on another website, it was copied illegally and reposted in violation of U.S. and international trademark & copyright law. The correct version of this piece of content can be accessed at https://www.americanbankingnews.com/2018/02/08/icon-iclr-set-to-announce-quarterly-earnings-on-thursday.html.

About Icon

ICON public limited company is a contract research organization (CRO), which is engaged in providing outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company is engaged in the strategic development, management and analysis of programs that support the various stages of the clinical development process, from compound selection to Phase I-IV clinical studies.

Earnings History for Icon (NASDAQ:ICLR)

Receive News & Ratings for Icon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Icon and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply